PDF) Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition
$ 6.00 · 4.6 (327) · In stock
IJMS, Free Full-Text
IJMS, Free Full-Text
Inhibition of TGF-β-induced EMT in MDA-MB-231 breast cancer cells by
Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells - ScienceDirect
Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation, BMC Cancer
Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming
Caveolin-1: a multifaceted driver of breast cancer progression and its
Frontiers The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma: Cancer Cell